Amgen profit beats estimates, weight-loss data due by year-end
安进(US:AMGN) Reuters·2025-11-05 05:04财务业绩 - 季度财务业绩超出华尔街预期 [1] - 产品销售额增长12% [1] 运营与研发 - 运营费用因实验性减肥药MariTi相关支出而增加 [1]
安进(US:AMGN) Reuters·2025-11-05 05:04安进(US:AMGN) Reuters·2025-11-05 05:04